Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study to Evaluate the Effect of 10% Metronidazole Ointment, Applied Topically Three Times a Day in and Around the Anus and the Change in Perianal Crohn's Disease Activity

NCT00509639 is registered in ClinicalTrials.gov with S.L.A. Pharma AG as lead sponsor.

NCT NCT00509639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00509639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study to Evaluate the Effect of 10% Metronidazole Ointment, Applied Topically Three Times a Day in and Around the Anus and the Change in Perianal Crohn's Disease Activity
Lead sponsor
S.L.A. Pharma AG
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2005
Completion date
February 29, 2008
Enrollment
74 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease